ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,059 | -22.3% | 29,703 | +0.5% | 0.01% | -14.3% |
| Q2 2023 | $1,363 | +16.4% | 29,553 | +1.2% | 0.01% | 0.0% |
| Q1 2023 | $1,171 | -12.8% | 29,193 | +0.7% | 0.01% | -12.5% |
| Q4 2022 | $1,343 | -99.9% | 28,983 | +1.3% | 0.01% | 0.0% |
| Q3 2022 | $1,185,000 | -29.7% | 28,613 | +1.3% | 0.01% | -27.3% |
| Q2 2022 | $1,685,000 | -3.3% | 28,243 | +17.7% | 0.01% | +10.0% |
| Q1 2022 | $1,742,000 | -12.2% | 23,989 | +1.6% | 0.01% | 0.0% |
| Q4 2021 | $1,985,000 | -5.2% | 23,609 | +1.7% | 0.01% | -16.7% |
| Q3 2021 | $2,093,000 | -2.2% | 23,209 | +3.5% | 0.01% | 0.0% |
| Q2 2021 | $2,139,000 | – | 22,430 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
| First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
| SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
| Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
| Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
| Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
| FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
| Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
| Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
| Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |